Lumos Biotech
lumosbio
"Imbalanced host response to #SARSCoV2 drives development of #COVID19" Highlighting "We propose that reduced innate #antiviral defenses coupled with exuberant inflammatory #cytokine production are the defining and driving feature
Read more
THREAD from the new #bradykinin research (pre-print) from :"We propose that the severity of the disease and many deaths are due to a local vascular problem due to activation of
Read more